Mitchell S. Kapoor Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Mitchell S. Kapoor

Stock Analyst at HC Wainwright & Co.

(4.05)
# 1943
Out of 5,493 analysts
31
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

20 Stocks

Name Action PT Current % Upside Ratings Updated
CRSP CRISPR Therapeutics
Reiterates: Buy
80 80
61.67 29.72% 1 Sep 23, 2025
IONS Ionis Pharmaceutical...
Reiterates: Buy
95 95
64.09 48.23% 3 Sep 23, 2025
HALO Halozyme Therapeutic...
Maintains: Strong Buy
75 85
73.75 15.25% 1 Sep 22, 2025
NTLA Intellia Therapeutic...
Maintains: Strong Buy
25 30
16.31 83.94% 2 Sep 19, 2025
AVTX Avalo Therapeutics
Maintains: Strong Buy
15 25
10.8 131.48% 1 Sep 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50 50
20.95 138.66% 5 Sep 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
125 125
16.93 638.33% 3 Sep 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
60
53.85 11.42% 1 Sep 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
3.24 54.32% 2 Sep 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 10
6.1 63.93% 1 Aug 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
n/a n/a 2 Aug 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Sell
5 5
18.36 -72.77% 1 Aug 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
12.97 131.3% 1 Aug 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
2.29 205.68% 1 Aug 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
3 2
2.41 -17.01% 1 Aug 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
45 45
n/a n/a 1 Aug 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 9
6.77 32.94% 1 Aug 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
14 14
4.05 245.68% 1 Aug 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
100 90
40.66 121.35% 1 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 4
1.14 250.88% 1 Aug 11, 2025